GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vistin Pharma ASA (OSL:VISTN) » Definitions » Cyclically Adjusted PS Ratio

Vistin Pharma ASA (OSL:VISTN) Cyclically Adjusted PS Ratio : 2.59 (As of Jun. 03, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Vistin Pharma ASA Cyclically Adjusted PS Ratio?

As of today (2025-06-03), Vistin Pharma ASA's current share price is kr26.30. Vistin Pharma ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was kr10.14. Vistin Pharma ASA's Cyclically Adjusted PS Ratio for today is 2.59.

The historical rank and industry rank for Vistin Pharma ASA's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSL:VISTN' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.13   Med: 2.39   Max: 2.8
Current: 2.56

During the past years, Vistin Pharma ASA's highest Cyclically Adjusted PS Ratio was 2.80. The lowest was 2.13. And the median was 2.39.

OSL:VISTN's Cyclically Adjusted PS Ratio is ranked worse than
56.1% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs OSL:VISTN: 2.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Vistin Pharma ASA's adjusted revenue per share data for the three months ended in Mar. 2025 was kr2.594. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr10.14 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vistin Pharma ASA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Vistin Pharma ASA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vistin Pharma ASA Cyclically Adjusted PS Ratio Chart

Vistin Pharma ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.36

Vistin Pharma ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.25 2.81 2.36 2.41

Competitive Comparison of Vistin Pharma ASA's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vistin Pharma ASA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Cyclically Adjusted PS Ratio falls into.


;
;

Vistin Pharma ASA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Vistin Pharma ASA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=26.30/10.14
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vistin Pharma ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Vistin Pharma ASA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.594/136.1000*136.1000
=2.594

Current CPI (Mar. 2025) = 136.1000.

Vistin Pharma ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.736 100.100 2.360
201509 5.301 100.600 7.172
201512 0.000 100.900 0.000
201603 5.960 102.500 7.914
201606 3.140 103.800 4.117
201609 2.192 104.200 2.863
201612 1.919 104.400 2.502
201703 2.560 105.000 3.318
201706 2.689 105.800 3.459
201709 2.781 105.900 3.574
201712 2.437 106.100 3.126
201803 3.062 107.300 3.884
201806 1.551 108.500 1.946
201809 1.141 109.500 1.418
201812 0.753 109.800 0.933
201903 0.845 110.400 1.042
201906 1.378 110.600 1.696
201909 1.534 111.100 1.879
201912 1.259 111.300 1.540
202003 1.385 111.200 1.695
202006 1.647 112.100 2.000
202009 1.242 112.900 1.497
202012 1.436 112.900 1.731
202103 1.597 114.600 1.897
202106 1.507 115.300 1.779
202109 1.417 117.500 1.641
202112 1.698 118.900 1.944
202203 0.749 119.800 0.851
202206 1.556 122.600 1.727
202209 2.068 125.600 2.241
202212 2.114 125.900 2.285
202303 2.276 127.600 2.428
202306 2.407 130.400 2.512
202309 2.705 129.800 2.836
202312 2.497 131.900 2.577
202403 2.343 132.600 2.405
202406 2.392 133.800 2.433
202409 2.387 133.700 2.430
202412 2.564 134.800 2.589
202503 2.594 136.100 2.594

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vistin Pharma ASA  (OSL:VISTN) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Vistin Pharma ASA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Vistin Pharma ASA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vistin Pharma ASA Business Description

Traded in Other Exchanges
Address
Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a Norway based pharmaceutical company. It is principally engaged in the business activity of producing active pharmaceutical ingredients (APIs) and solid dosage forms for the pharmaceutical industry. The company has two business segments namely Pharmaceuticals and Energy Trading. The group has operations in Norway, Germany, Switzerland, Great Britain, Algeria and other countries.

Vistin Pharma ASA Headlines

No Headlines